Vanda Pharmaceuticals reported $54.53M in Gross Profit on Sales for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Gross Profit On Sales Change
Acadia Pharmaceuticals ACAD:US $ 112.52M 15.68M
Alnylam Pharmaceuticals ALNY:US $ 177.63M 43.24M
Anika Therapeutics ANIK:US $ 21.8M 3.67M
AstraZeneca AZN:LN 8.94B 2.9B
Bristol Myers Squibb BMY:US $ 9177M 452M
Clovis Oncology CLVS:US $ 24.83M 1.4M
Eli Lilly And LLY:US $ 5737.9M 211.8M
Esperion Therapeutics ESPR:US $ 11.71M 1.38M
Halozyme Therapeutics HALO:US $ 101.36M 20.94M
Insmed INSM:US $ 40.92M 1.92M
Intercept Pharmaceuticals ICPT:US $ 87.82M 3.57M
Johnson & Johnson JNJ:US $ 15828M 1021M
Ligand Pharmaceuticals LGND:US $ 40.99M 19.5M
Merk MRK:US $ 10567M 873M
Moderna Inc MRNA:US 5.05B 1.21B
Novartis NVS:US $ 9059M 463M
Pfizer PFE:US $ 15651M 1516M
Puma Biotechnology PBYI:US $ 34.89M 8.57M
Takeda 4502:JP Y 564909M 54981M
Teva Pharmaceutical TEVA:IT 2.12B 227M
Ultragenyx Pharmaceutical RARE:US $ 73.83M 6.04M